Preclinical promise of becaplermin (rhPDGF-BB) in wound healing

American Journal of Surgery

Volumn 176, Issue 2 A, 1998, Pages 48S-54S

  LeGrand, Edmund K ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

DRUG EFFECT; DRUG USE; GRANULATION TISSUE; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN ULCER; WOUND; WOUND HEALING;

EID: 0031657229     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00177-9     Document Type: Article

References (48)

1. Yager DR, Zhang L-Y, Liang H-X, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol. 1996;107:743-748.
2. Wysocki AB. Wound fluids and the pathogenesis of chronic wounds. J Wound Ostomy Continence Nurs. 1996;23:283-290.
3. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4:411-420.
4. Yager DR, Chen SM, Ward SI, et al. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen. 1997;5:23-32.
5. Schaffer CJ, Narrey LB. Cell biology of wound healing. Int Rev Cytol. 1996;169:151-181.
6. Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med. 1993; 4:729-760.
7. Pierce GF, Mustoe TA, Altrock BW, et al. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45: 319-326.
8. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Repair Regen. 1997;5:12-17.
9. LeGrand EK, Niciporciukas MC, Donetz AP, et al. Comparison of pig and guinea pig full and partial thickness skin excision wound models for evaluating the effects of rhPDGF-BB. Wounds. 1995;7: 78-89.
10. LeGrand EK, Senter LH, Gamelli RL, Kiorpes TC. Evaluation of PDGF-BB, PDGF-AA, bFGF, IL-1, and EGF dose responses in polyvinyl alcohol sponge implants assessed by a rapid histologic method. Growth Factors. 1993;8:315-329.
11. LeGrand EK, Burke JF, Costa DE, Kiorpes TC. Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model. Growth Factors. 1993;8:307-314.
12. Senter LH, LeGrand EK, Laemmerhirt KE, Kiorpes TC. Assessment of full-thickness wounds in the genetically diabetic mouse for suitability as a wound healing model. Wound Repair Regen. 1995;3:351-358.
13. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest. 1991;87:694-703.
14. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136:1235-1246.
15. Robson M, Kucukcelebi A, Carp SS, et al. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur J Clin Microbiol Infect Dis. 1994;13(Suppl 2):S41-S46.
16. Heggers JP, Haydon S, Ko F, et al. Pseudomonas aeruginosa exotoxin A: its role in retardation of wound healing: the 1992 Lindberg Award. J Burn Care Rehabil. 1992;13:512-518.
17. Hayward P, Hokanson J, Heggers J, et al. Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg. 1992;163:288-293.
18. Stenberg BD, Phillips LG, Hokanson JA, et al. Effect of bFGF on the inhibition of contraction caused by bacteria. J Surg Res. 1991;50:47-50.
19. Ahn ST, Mustoe TA. Effects of ischemia on ulcer wound healing: a new model in the rabbit ear. Ann Plast Surg. 1990;24: 17-23.
20. Grotendorst GR, Martin GR, Pencev D, et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest. 1985;76:2323-2329.
21. Engrav LH, Richey KJ, Kao CC, et al. Topical growth factors and wound contraction in the rat. Part II: Platelet-derived growth factor and wound contraction in normal and steroid-impaired rats. Ann Plast Surg. 1989;23:245-248.
22. Pierce GF, Tarpley JE, Yanagihara D, et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-β1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol. 1992; 140:1375-1388.
23. Zhao LL, Davidson JD, Wee SC, et al. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg. 1994;129:1043-1049.
24. Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res. 1994;56:562-570.
25. Greenhalgh DG, Hummel RP, Albertson S, et al. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo: enhancement of tissue repair in genetically diabetic mice. Wound Repair Regen. 1993;1:69-81.
26. Albertson S, Hummel RP, Breedon M, et al. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery. 1993;114:368-373.
27. Kiritsy CP, Antoniades HN, Carlson MR, et al. Combination of platelet-derived growth factor-BB and insulin-like growth factor-1 is more effective than platelet-derived growth factor-BB alone in stimulating complete healing of full-thickness wounds in "older" diabetic mice. Wound Repair Regen. 1995;3:340-350.
28. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest. 1989;84:640-646.
29. Hill E, Turner-Beatty M, Grotewiel M, et al. The effect of PDGF on the healing of full thickness wounds in hairless guinea pigs. Comp Biochem Physiol 1991;100A:365-370.
30. Lawrence WT, Sporn MB, Gorschboth C, et al. The reversal of an Adriamycin® induced healing impairment with chemoattractants and growth factors. Ann Surg. 1986;203:142-147.
31. Royce PM, Kato T, Ohsaki K, et al. The enhancement of cellular infiltration and vascularisation of a collagenous dermal implant in the rat by platelet-derived growth factor BB. J Dermatol Sci. 1995;10:42-52.
32. Khouri RK, Koudsl B, Deune EG, et al. Tissue generation with growth factors. Surgery. 1993;114:374-380.
33. Lepisto J, Laato M, Nilinkoski J, et al. Effects of homodimeric isoforms of platelet-derived growth factor (PDGF-AA and PDGF-BB) on wound healing in rat. J Surg Res. 1992;53:596-601.
34. Sprugel KH, McPherson JM, Clowes AW, et al. Effects of growth factors in vivo. I: Cell ingrowth into porous subcutaneous chambers. Am J Pathol. 1987;129:601-613.
35. Ogawa Y, Ksander GA, Pratt BM, et al. Differences in the biological activities of transforming growth factor-β and platelet-derived growth factor in vivo. Growth Factors. 1991;5:57-68.
36. Dvorak HF, Harvey VS, Estrella P, et al. Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab Invest. 1987;57:673-686.
37. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med. 1988; 167:974-987.
38. Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-440.
39. 1 therapy. J Lab Clin Med. 1991;117:373-382.
40. Mustoe TA, Purdy J, Gramates P, et al. Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Am J Surg. 1989;158:345-350.
41. Pierce GF, Mustoe TA, Lingelbach J, et al. Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA. 1989;86:2229-2233.
42. Wu L, Mustoe TA. Effect of ischemia on growth factor enhancement of incisional wound healing. Surgery. 1995;117:570-576.
43. Mustoe TA, Landes A, Cromack DT, et al. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor type beta. Surgery. 1990;108:324-330.
44. Letson AK, Dahners LE. The effect of combinations of growth factors on ligament healing. Clin Orthop. 1994;308:207-212.
45. Murali S, Hardten DR, DeMartelaere S, et al. Effect of topically administered platelet-derived growth factor on corneal wound strength. Curr Eye Res. 1994;13:857-862.
46. Stern ME, Waltz KM, Beurerman RW, et al. Effect of platelet-derived growth factor on rabbit corneal wound healing. Wound Repair Regen 1995;3:59-65.
47. Steed DL, the Diabetic Ulcer Study Group. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vase Surg. 1995;21:71-81.
48. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with nonhealing diabetic ulcers: a phase III, randomized, placebo-controlled, double-blind study. Diabetes Care. 1998;21:822-830.